Fabrizio Conti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view	ANNALS OF THE RHEUMATIC DISEASES	2020
COVID-19. an unexpected indication for anti-rheumatic therapies	RHEUMATOLOGY	2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis. a real-life multicenter study	EXPERT OPINION ON BIOLOGICAL THERAPY	2020
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients	JOURNAL OF AUTOIMMUNITY	2020
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica	SCIENTIFIC REPORTS	2020
Targeting the immune system for pulmonary iInflammation and cardiovascular complications in COVID-19 patients	FRONTIERS IN IMMUNOLOGY	2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells	EBIOMEDICINE	2020
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion	CLINICAL AND TRANSLATIONAL IMMUNOLOGY	2020
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)	AUTOPHAGY	2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells	ANNALS OF ONCOLOGY	2020
Joint involvement influences quality of life in systemic lupus erythematosus patients	LUPUS	2020
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis	RHEUMATOLOGY	2020
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2020
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX	Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES	2020
FRI0159 EROSIVE ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: APPLICATION OF CLUSTER ANALYSIS	Annals of the Rheumatic DiseasesANNALS OF THE RHEUMATIC DISEASES	2020
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients	LUPUS	2020
Treatment with gonadotropin releasing hormone agonists in systemic lupus erythematosus patients receiving cyclophosphamide: A long-term follow-up study	ISRAEL MEDICAL ASSOCIATION JOURNAL	2020
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study	ISRAEL MEDICAL ASSOCIATION JOURNAL	2020
The Impact of Caffeine Intake on Patients with Systemic Lupus Erythematosus: Protect Yourself, Drink More Coffee!	MEDITERRANEAN JOURNAL OF RHEUMATOLOGY	2020
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort	CLINICAL RHEUMATOLOGY	2020

Progetti di Ricerca

MODULATION OF NEURO-IMMUNE INTERACTION THROUGH JAK INHIBITION IN RHEUMATOID ARTHRITIS
Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation.
Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine